Viewing data from:

QUININE SULFATE

ANDA

QUININE SULFATE | A091661 | TEVA PHARMACEUTICALS USA

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.7200

per ea

Lowest NADAC/Unit

$0.7200

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093300256QUININE SULFATE 324 MG CAPSULE	$0.7200	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs4 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

BUCHLER GMBHQUININE SULFATE, USP

DMF 170862004

SHIVA INTERNATIONALQUININE SULFATE USP

DMF 240632010

DSM MINERA BVInactiveQUININE SULFATE USP XIX/ NF XII

DMF 33981978

BOEHRINGER MANNHEIM GMBHInactiveQUININE SULFATE

DMF 94621991

PT SINKONA INDONESIA LESTARIInactiveQUININE SULFATE USP

DMF 199052006

PT KIMIA FARMA PERSERO TBKInactiveQUININE SULFATE

DMF 209512007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 324MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Sep 28, 2012

No patent or exclusivity listings for this strength.